Search Results for "Novorapid"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Novorapid. Results 1 to 2 of 2 total matches.
In Brief: Merilog — A NovoLog Biosimilar
The Medical Letter on Drugs and Therapeutics • Jun 23, 2025 (Issue 1731)
biosimilars NovoLog Novorapid ...
The FDA has approved Merilog (Sanofi), a biosimilar to
rapid-acting insulin aspart (NovoLog), for treatment of
patients with type 1 or type 2 diabetes. Merilog is the
first rapid-acting insulin biosimilar product to become
available in the US.
Med Lett Drugs Ther. 2025 Jun 23;67(1731):104 doi:10.58347/tml.2025.1731c | Show Introduction Hide Introduction
Lyumjev - A New Insulin Lispro for Diabetes
The Medical Letter on Drugs and Therapeutics • Oct 19, 2020 (Issue 1609)
Fiasp Humalog insulin Lyumjev NovoLog Novorapid type 1 diabetes type 2 diabetes ...
The FDA has approved insulin lispro-aabc (Lyumjev –
Lilly), a faster-acting formulation of insulin lispro
(Humalog), for treatment of type 1 and type 2 diabetes
in adults. Fiasp, a faster-acting formulation of insulin
aspart (Novolog), was approved in 2017.